Wake-active neurons across aging and neurodegeneration: a potential role for sleep disturbances in promoting disease

SpringerPlus

Volumn 4, Issue 1, 2015, Pages

  Stern, Anna L ^a   Naidoo, Nirinjini ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Aging; Daytime sleepiness; Fragmentation; Neurodegeneration; Sleep

Indexed keywords

EID: 84961289931     PISSN: None     EISSN: 21931801     Source Type: Journal    
DOI: 10.1186/s40064-014-0777-6     Document Type: Article

References (170)

1. Abbott RD, Ross GW, White LR, Tanner CM, Masaki KH, Nelson JS, Curb JD, Petrovitch H (2005) Excessive daytime sleepiness and subsequent development of Parkinson disease. Neurology 65:1442–1446, doi:10.1212/01.wnl.0000183056.89590.0d
2. Adamantidis AR, Zhang F, Aravanis AM, Deisseroth K, de Lecea L (2007) Neural substrates of awakening probed with optogenetic control of hypocretin neurons. Nature 450:420–424, doi:10.1038/nature06310
3. Anderson KN, Hatfield C, Kipps C, Hastings M, Hodges JR (2009) Disrupted sleep and circadian patterns in frontotemporal dementia. Eur J Neurol 16:317–323, doi:10.1111/j.1468-1331.2008.02414.x
4. Anichtchik OV, Rinne JO, Kalimo H, Panula P (2000) An altered histaminergic innervation of the substantia nigra in Parkinson’s disease. Exp Neurol 163:20–30, doi:10.1006/exnr.2000.7362
5. Arnulf I, Leu-Semenescu S (2009) Sleepiness in Parkinson’s disease. Parkinsonism Relat Disord 15(Suppl 3):S101–S104, doi:10.1016/S1353-8020(09)70792-8
6. Basheer R, Bauer A, Elmenhorst D, Ramesh V, McCarley RW (2007) Sleep deprivation upregulates A1 adenosine receptors in the rat basal forebrain. Neuroreport 18:1895–1899, doi:10.1097/WNR.0b013e3282f262f6
7. Bassetti CL, Baumann CR, Dauvilliers Y, Croyal M, Robert P, Schwartz JC (2010) Cerebrospinal fluid histamine levels are decreased in patients with narcolepsy and excessive daytime sleepiness of other origin. J Sleep Res 19:620–623, doi:10.1111/j.1365-2869.2010.00819.x
8. Benarroch EE, Schmeichel AM, Dugger BN, Sandroni P, Parisi JE, Low PA (2009) Dopamine cell loss in the periaqueductal gray in multiple system atrophy and Lewy body dementia. Neurology 73:106–112, doi:10.1212/WNL.0b013e3181ad53e7
9. Bixler EO, Vgontzas AN, Lin H-M, Calhoun SL, Vela-Bueno A, Kales A (2005) Excessive daytime sleepiness in a general population sample: the role of sleep apnea, age, obesity, diabetes, and depression. J Clin Endocrinol Metab 90:4510–4515, doi:10.1210/jc.2005-0035
10. Bliwise DL (1993) Sleep in normal aging and dementia. Sleep 16:40–81
11. Bloom GS (2014) Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol 71:505–508, doi:10.1001/jamaneurol.2013.5847
12. Boeve BF, Silber MH, Saper CB, Ferman TJ, Dickson DW, Parisi JE, Benarroch EE, Ahlskog JE, Smith GE, Caselli RC, Tippman-Peikert M, Olson EJ, Lin SC, Young T, Wszolek Z, Schenck CH, Mahowald MW, Castillo PR, Del Tredici K, Braak H (2007) Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain 130:2770–2788, doi:10.1093/brain/awm056
13. Bolitho SJ, Naismith SL, Salahuddin P, Terpening Z, Grunstein RR, Lewis SJ (2013) Objective measurement of daytime napping, cognitive dysfunction and subjective sleepiness in Parkinson’s disease. PLoS One 8:e81233, doi:10.1371/journal.pone.0081233
14. Bonakis A, Economou N-T, Paparrigopoulos T, Bonanni E, Maestri M, Carnicelli L, Di Coscio E, Ktonas P, Vagiakis E, Theodoropoulos P, Papageorgiou SG (2014) Sleep in frontotemporal dementia is equally or possibly more disrupted, and at an earlier stage, when compared to sleep in Alzheimer’s disease. J Alzheimers Dis 38:85–91, doi:10.3233/JAD-122014
15. Bonanni E, Maestri M, Tognoni G, Fabbrini M, Nucciarone B, Manca ML, Gori S, Iudice A, Murri L (2005) Daytime sleepiness in mild and moderate Alzheimer’s disease and its relationship with cognitive impairment. J Sleep Res 14:311–317, doi:10.1111/j.1365-2869.2005.00462.x
16. Bouras C, Hof PR, Giannakopoulos P, Michel JP, Morrison JH (1994) Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: a quantitative evaluation of a one-year autopsy population from a geriatric hospital. Cereb Cortex 4:138–50
17. Bowen DM, Procter AW, Mann DMA, Snowden JS, Esiri MM, Neary D, Francis PT (2008) Imbalance of a serotonergic system in frontotemporal dementia: implication for pharmacotherapy. Psychopharmacology (Berl) 196:603–610, doi:10.1007/s00213-007-0992-8
18. Braak H, Ghebremedhin E, Rüb U, Bratzke H, Del Tredici K (2004) Stages in the development of Parkinson’s disease-related pathology. Cell Tissue Res 318:121–134, doi:10.1007/s00441-004-0956-9
19. Braak H, Thal DR, Ghebremedhin E, Del Tredici K (2011) Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol 70:960–969, doi:10.1097/NEN.0b013e318232a379
20. Brioni JD, Esbenshade TA, Garrison TR, Bitner SR, Cowart MD (2011) Discovery of histamine H3 antagonists for the treatment of cognitive disorders and Alzheimer’s disease. J Pharmacol Exp Ther 336:38–46, doi:10.1124/jpet.110.166876
21. Brown MK, Naidoo N (2012) The endoplasmic reticulum stress response in aging and age-related diseases. Front Physiol 3:263, doi:10.3389/fphys.2012.00263
22. Brownell SE, Conti B (2010) Age- and gender-specific changes of hypocretin immunopositive neurons in C57Bl/6 mice. Neurosci Lett 472:29–32, doi:10.1016/j.neulet.2010.01.048
23. Brunnström H, Friberg N, Lindberg E, Englund E (2011) Differential degeneration of the locus coeruleus in dementia subtypes. Clin Neuropathol 30:104–10
24. Burke RE, Dauer WT, Vonsattel JPG (2008) A critical evaluation of the Braak staging scheme for Parkinson’s disease. Ann Neurol 64:485–491, doi:10.1002/ana.21541
25. Carter ME, Yizhar O, Chikahisa S, Nguyen H, Adamantidis A, Nishino S, Deisseroth K, de Lecea L (2010) Tuning arousal with optogenetic modulation of locus coeruleus neurons. Nat Neurosci 13:1526–1533, doi:10.1038/nn.2682
26. Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, Lee C, Richardson JA, Williams SC, Xiong Y, Kisanuki Y, Fitch TE, Nakazato M, Hammer RE, Saper CB, Yanagisawa M (1999) Narcolepsy in orexin knockout mice molecular genetics of sleep regulation. Cell 98:437–451, doi:10.1016/S0092-8674(00)81973-X
27. Chen CPL-H, Eastwood SL, Hope T, McDonald B, Francis PT, Esiri MM (2000) Immunocytochemical study of the dorsal and median raphe nuclei in patients with Alzheimer’s disease prospectively assessed for behavioural changes. Neuropathol Appl Neurobiol 26:347–355, doi:10.1046/j.1365-2990.2000.00254.x
28. Çoban A, Bilgiç B, Lohmann E, Küçükali Cİ, Benbir G, Karadeniz D, Hanagasi HA, Tüzün E, Gürvit H (2013) Reduced orexin-A levels in frontotemporal dementia: possible association with sleep disturbance. Am J Alzheimers Dis Other Demen 28:606–611, doi:10.1177/1533317513494453
29. Conte F, Arzilli C, Errico BM, Giganti F, Iovino D, Ficca G (2014) Sleep measures expressing “functional uncertainty” in elderlies’ sleep. Gerontology 60:448–457, doi:10.1159/000358083
30. De Cock VC, Vidailhet M, Arnulf I (2008) Sleep disturbances in patients with parkinsonism. Nat Clin Pract Neurol 4:254–266, doi:10.1038/ncpneuro0775
31. De Lecea L, Huerta R (2014) Hypocretin (orexin) regulation of sleep-to-wake transitions. Front Pharmacol 5:16, doi:10.3389/fphar.2014.00016
32. De Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE, Fukuhara C, Battenberg EL, Gautvik VT, Bartlett FS 2nd, Frankel WN, van den Pol AN, Bloom FE, Gautvik KM, Sutcliffe JG (1998) The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci 95:322–327, doi:10.1073/pnas.95.1.322
33. Di Lazzaro V, Pilato F, Dileone M, Saturno E, Oliviero A, Marra C, Daniele A, Ranieri F, Gainotti G, Tonali PA (2006) In vivo cholinergic circuit evaluation in frontotemporal and Alzheimer dementias. Neurology 66:1111–1113, doi:10.1212/01.wnl.0000204183.26231.23
34. Downs JL, Dunn MR, Borok E, Shanabrough M, Horvath TL, Kohama SG, Urbanski HF (2007) Orexin neuronal changes in the locus coeruleus of the aging rhesus macaque. Neurobiol Aging 28:1286–1295, doi:10.1016/j.neurobiolaging.2006.05.025
35. Fernandez-Novoa L (2001) Histamine function in brain disorders. Behav Brain Res 124:213–233, doi:10.1016/S0166-4328(01)00215-7
36. Foley DJ, Vitiello MV, Bliwise DL, Ancoli-Israel S, Monjan AA, Walsh JK (2007) Frequent napping is associated with excessive daytime sleepiness, depression, pain, and nocturia in older adults: findings from the national sleep foundation “2003 Sleep in America” Poll. Am J Geriatr psychiatry 15:344–350, doi:10.1097/01.JGP.0000249385.50101.67
37. Fronczek R, Overeem S, Lee SYY, Hegeman IM, van Pelt J, van Duinen SG, Lammers GJ, Swaab DF (2007) Hypocretin (orexin) loss in Parkinson’s disease. Brain 130:1577–1585, doi:10.1093/brain/awm090
38. Fronczek R, van Geest S, Frölich M, Overeem S, Roelandse FW, Lammers GJ, Swaab DF (2012) Hypocretin (orexin) loss in Alzheimer’s disease. Neurobiol Aging 33:1642–1650, doi:10.1016/j.neurobiolaging.2011.03.014
39. Gardner JP, Fornal CA, Jacobs BL (1997) Effects of sleep deprivation on serotonergic neuronal activity in the dorsal raphe nucleus of the freely moving cat. Neuropsychopharmacology 17:72–81, doi:10.1016/S0893-133X(97)00025-0
40. Gong Y, Xiong K-P, Mao C-J, Shen Y, Hu WD, Huang JY, Han F, Chen R, Liu CF (2014) Clinical manifestations of Parkinson disease and the onset of rapid eye movement sleep behavior disorder. Sleep Med 15:647–653, doi:10.1016/j.sleep.2013.12.021
41. González MMC, Aston-Jones G (2006) Circadian regulation of arousal: role of the noradrenergic locus coeruleus system and light exposure. Sleep 29:1327–1336
42. Gooneratne NS, Vitiello MV (2014) Sleep in older adults: normative changes, sleep disorders, and treatment options. Clin Geriatr Med 30:591–627, doi:10.1016/j.cger.2014.04.007
43. Gratwicke J, Kahan J, Zrinzo L, Hariz M, Limousin P, Foltynie T, Jahanshahi M (2013) The nucleus basalis of Meynert: a new target for deep brain stimulation in dementia? Neurosci Biobehav Rev 37:2676–2688, doi:10.1016/j.neubiorev.2013.09.003
44. Grivel J, Cvetkovic V, Bayer L, Machard D, Tobler I, Mühlethaler M, Serafin M (2005) The wake-promoting hypocretin/orexin neurons change their response to noradrenaline after sleep deprivation. J Neurosci 25:4127–4130, doi:10.1523/JNEUROSCI.0666-05.2005
45. Grothe M, Zaborszky L, Atienza M, Gil-Neciga E, Rodriguez-Romero R, Teipel SJ, Amunts K, Suarez-Gonzalez A, Cantero JL (2010) Reduction of basal forebrain cholinergic system parallels cognitive impairment in patients at high risk of developing Alzheimer’s disease. Cereb Cortex 20:1685–1695, doi:10.1093/cercor/bhp232
46. Grothe M, Heinsen H, Teipel SJ (2012) Atrophy of the cholinergic Basal forebrain over the adult age range and in early stages of Alzheimer’s disease. Biol Psychiatry 71:805–813, doi:10.1016/j.biopsych.2011.06.019
47. Grothe MJ, Schuster C, Bauer F, Heinsen H, Prudlo J, Teipel SJ. (2014) Atrophy of the cholinergic basal forebrain in dementia with Lewy bodies and Alzheimer’s disease dementia. J Neurol 1–10. doi:10.1007/s00415-014-7439-z
48. Grudzien A, Shaw P, Weintraub S, Bigio E, Mash DC, Mesulam MM (2007) Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer’s disease. Neurobiol Aging 28:327–335, doi:10.1016/j.neurobiolaging.2006.02.007
49. Guarnieri B, Adorni F, Musicco M, Appollonio I, Bonanni E, Caffarra P, Caltagirone C, Cerroni G, Concari L, Cosentino FI, Ferrara S, Fermi S, Ferri R, Gelosa G, Lombardi G, Mazzei D, Mearelli S, Morrone E, Murri L, Nobili FM, Passero S, Perri R, Rocchi R, Sucapane P, Tognoni G, Zabberoni S, Sorbi S (2012) Prevalence of sleep disturbances in mild cognitive impairment and dementing disorders: a multicenter Italian clinical cross-sectional study on 431 patients. Dement Geriatr Cogn Disord 33:50–58, doi:10.1159/000335363
50. Halliday GM, Blumbergs PC, Cotton RG, Blessing WW, Geffen LB (1990) Loss of brainstem serotonin- and substance P-containing neurons in Parkinson’s disease. Brain Res 510:104–107
51. Halloran M, Parakh S, Atkin JD (2013) The role of s-nitrosylation and s-glutathionylation of protein disulphide isomerase in protein misfolding and neurodegeneration. Int J Cell Biol 2013:797914, doi:10.1155/2013/797914
52. Hasselmo ME, Sarter M (2011) Modes and models of forebrain cholinergic neuromodulation of cognition. Neuropsychopharmacology 36:52–73, doi:10.1038/npp.2010.104
53. Hemmeter U-M, Hemmeter-Spernal J, Krieg J-C (2010) Sleep deprivation in depression. Expert Rev Neurother 10:1101–1115, doi:10.1586/ern.10.83
54. Heneka MT, Ramanathan M, Jacobs AH, Dumitrescu-Ozimek L, Bilkei-Gorzo A, Debeir T, Sastre M, Galldiks N, Zimmer A, Hoehn M, Heiss WD, Klockgether T, Staufenbiel M (2006) Locus ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice. J Neurosci 26:1343–1354, doi:10.1523/JNEUROSCI.4236-05.2006
55. Hipólide DC, Moreira KM, Barlow KBL, Wilson AA, Nobrega JN, Tufik S (2005) Distinct effects of sleep deprivation on binding to norepinephrine and serotonin transporters in rat brain. Prog Neuropsychopharmacol Biol Psychiatry 29:297–303, doi:10.1016/j.pnpbp.2004.11.015
56. Hirano S, Shinotoh H, Shimada H, Aotsuka A, Tanaka N, Ota T, Sato K, Ito H, Kuwabara S, Fukushi K, Irie T, Suhara T (2010) Cholinergic imaging in corticobasal syndrome, progressive supranuclear palsy and frontotemporal dementia. Brain 133:2058–2068, doi:10.1093/brain/awq120
57. Hoogendijk WJ, Pool CW, Troost D, van Zwieten E, Swaab DF (1995) Image analyser-assisted morphometry of the locus coeruleus in Alzheimer’s disease, Parkinson's disease and amyotrophic lateral sclerosis. Brain 118(Pt 1):131–143
58. Huang ZL, Qu WM, Li WD, Mochizuki T, Eguchi N, Watanabe T, Urade Y, Hayaishi O (2001) Arousal effect of orexin A depends on activation of the histaminergic system. Proc Natl Acad Sci U S A 98:9965–9970, doi:10.1073/pnas.181330998
59. Ikonomovic MD, Nocera R, Mizukami K, Armstrong DM (2000) Age-related loss of the AMPA receptor subunits GluR2/3 in the human nucleus basalis of Meynert. Exp Neurol 166:363–375, doi:10.1006/exnr.2000.7544
60. Iraizoz I, Guijarro JL, Gonzalo LM, de Lacalle S (1999) Neuropathological changes in the nucleus basalis correlate with clinical measures of dementia. Acta Neuropathol 98:186–196
61. Iranzo A, Gelpi E, Tolosa E, Molinuevo JL, Serradell M, Gaig C, Santamaria J (2014) Neuropathology of prodromal Lewy body disease. Mov Disord 29:410–415, doi:10.1002/mds.25825
62. Ishunina TA, van Heerikhuize JJ, Ravid R, Swaab DF (2003) Estrogen receptors and metabolic activity in the human tuberomamillary nucleus: changes in relation to sex, aging and Alzheimer’s disease. Brain Res 988:84–96, doi:10.1016/S0006-8993(03)03347-X
63. Iwanaga K, Wakabayashi K, Honma Y, Takahashi H (1997) Amyotrophic lateral sclerosis: occurrence of Bunina bodies in the locus ceruleus pigmented neurons. Clin Neuropathol 16:23–6
64. Jaussent I, Bouyer J, Ancelin M-L, Berr C, Foubert-Samier A, Ritchie K, Ohayon MM, Besset A, Dauvilliers Y (2012) Excessive sleepiness is predictive of cognitive decline in the elderly. Sleep 35:1201–1207, doi:10.5665/sleep.2070
65. Kalinchuk AV, McCarley RW, Porkka-Heiskanen T, Basheer R (2010) Sleep deprivation triggers inducible nitric oxide-dependent nitric oxide production in wake-active basal forebrain neurons. J Neurosci 30:13254–13264, doi:10.1523/JNEUROSCI.0014-10.2010
66. Kang J-E, Lim MM, Bateman RJ, Lee JJ, Smyth LP, Cirrito JR, Fujiki N, Nishino S, Holtzman DM (2009) Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science 326:1005–1007, doi:10.1126/science.1180962
67. Karageorgiou E, Miller BL (2014) Frontotemporal lobar degeneration: a clinical approach. Semin Neurol 34:189–201, doi:10.1055/s-0034-1381735
68. Kessler BA, Stanley EM, Frederick-Duus D, Fadel J (2011) Age-related loss of orexin/hypocretin neurons. Neuroscience 178:82–88, doi:10.1016/j.neuroscience.2011.01.031
69. Kim Y, Chen L, McCarley RW, Strecker RE (2013) Sleep allostasis in chronic sleep restriction: the role of the norepinephrine system. Brain Res 1531:9–16, doi:10.1016/j.brainres.2013.07.048
70. Klerman EB, Dijk D-J (2008) Age-related reduction in the maximal capacity for sleep–implications for insomnia. Curr Biol 18:1118–1123, doi:10.1016/j.cub.2008.06.047
71. Klöppel S, Kovacs GG, Voigtländer T, Wanschitz J, Flicker H, Hainfellner JA, Guentchev M, Budka H (2001) Serotonergic nuclei of the raphe are not affected in human ageing. Neuroreport 12:669–671
72. Kumakura Y, Danielsen EH, Gjedde A, Vernaleken I, Buchholz HG, Heinz A, Gründer G, Bartenstein P, Cumming P (2010) Elevated [(18)F]FDOPA utilization in the periaqueductal gray and medial nucleus accumbens of patients with early Parkinson’s disease. Neuroimage 49:2933–2939, doi:10.1016/j.neuroimage.2009.11.035
73. Lai MK, Tsang SW, Alder JT, Keene J, Hope T, Esiri MM, Francis PT, Chen CP (2005) Loss of serotonin 5-HT2A receptors in the postmortem temporal cortex correlates with rate of cognitive decline in Alzheimer’s disease. Psychopharmacology (Berl) 179:673–677, doi:10.1007/s00213-004-2077-2
74. Langston JW, Foltynie T, Kahan J (2013) Parkinson’s disease: an update on pathogenesis and treatment. J Neurol. doi:10.1007/s00415-013-6915-1
75. Lemoine P, Nir T, Laudon M, Zisapel N (2007) Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects. J Sleep Res 16:372–380, doi:10.1111/j.1365-2869.2007.00613.x
76. Lessig S, Ubhi K, Galasko D, Adame A, Pham E, Remidios K, Chang M, Hansen LA, Masliah E (2010) Reduced hypocretin (orexin) levels in dementia with Lewy bodies. Neuroreport 21:756–760, doi:10.1097/WNR.0b013e32833bfb7c
77. Li Y, Panossian LA, Zhang J, Zhu Y, Zhan G, Chou YT, Fenik P, Bhatnagar S, Piel DA, Beck SG, Veasey S (2013) Effects of Chronic Sleep Fragmentation on Wake-Active Neurons and the Hypercapneic Arousal Response. Sleep 37:51–64
78. Lim ASP, Kowgier M, Yu L, Buchman AS, Bennett DA (2013a) Sleep fragmentation and the risk of incident Alzheimer’s disease and cognitive decline in older persons. Sleep 36:1027–1032, doi:10.5665/sleep.2802
79. Lim ASP, Yu L, Kowgier M, Schneider JA, Buchman AS, Bennett DA (2013b) Modification of the relationship of the apolipoprotein E ε4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep. JAMA Neurol 70:1544–1551, doi:10.1001/jamaneurol.2013.4215
80. Lima MMS (2013) Sleep disturbances in Parkinson’s disease: The contribution of dopamine in REM sleep regulation. Sleep Med Rev. doi:10.1016/j.smrv.2012.10.006
81. Lin L, Faraco J, Li R, Kadotani H, Rogers W, Lin X, Qiu X, de Jong PJ, Nishino S, Mignot E (1999) The sleep disorder canine narcolepsy is caused by a mutation in the Hypocretin (Orexin) receptor 2 gene. Cell 98:365–376, doi:10.1016/S0092-8674(00)81965-0
82. Lo Coco D, La Bella V (2012) Fatigue, sleep, and nocturnal complaints in patients with amyotrophic lateral sclerosis. Eur J Neurol 19:760–763, doi:10.1111/j.1468-1331.2011.03637.x
83. Lo Coco D, Mattaliano P, Spataro R, Mattaliano A, La Bella V (2011) Sleep-wake disturbances in patients with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 82:839–842, doi:10.1136/jnnp.2010.228007
84. Lu J, Jhou TC, Saper CB (2006) Identification of wake-active dopaminergic neurons in the ventral periaqueductal gray matter. J Neurosci 26:193–202, doi:10.1523/JNEUROSCI.2244-05.2006
85. Lyseng-Williamson KA (2012) Melatonin prolonged release: in the treatment of insomnia in patients aged ≥55 years. Drugs Aging 29:911–923, doi:10.1007/s40266-012-0018-z
86. Mander BA, Rao V, Lu B, Saletin JM, Lindquist JR, Ancoli-Israel S, Jagust W, Walker MP (2013) Prefrontal atrophy, disrupted NREM slow waves and impaired hippocampal-dependent memory in aging. Nat Neurosci 16:357–364, doi:10.1038/nn.3324
87. Manfridi A, Brambilla D, Mancia M (1999) Stimulation of NMDA and AMPA receptors in the rat nucleus basalis of Meynert affects sleep. Am J Physiol 277:R1488–R1492
88. Marcusson JO, Morgan DG, Winblad B, Finch CE (1984) Serotonin-2 binding sites in human frontal cortex and hippocampus. Selective loss of S-2A sites with age. Brain Res 311:51–56, doi:10.1016/0006-8993(84)91397-0
89. Matsuki T, Takasu M, Hirose Y, Murakoshi N, Sinton CM, Motoike T, Yanagisawa M (2014) GABAA receptor-mediated input change on orexin neurons following sleep deprivation in mice. Neuroscience 284C:217–224, doi:10.1016/j.neuroscience.2014.09.063
90. Matsuoka T, Fujii N, Kondo A, Iwaki A, Hokonohara T, Honda H, Sasaki K, Suzuki SO, Iwaki T (2011) An autopsied case of sporadic adult-onset amyotrophic lateral sclerosis with FUS-positive basophilic inclusions. Neuropathology 31:71–76, doi:10.1111/j.1440-1789.2010.01129.x
91. Merlino G, Piani A, Gigli GL, Cancelli I, Rinaldi A, Baroselli A, Serafini A, Zanchettin B, Valente M (2010) Daytime sleepiness is associated with dementia and cognitive decline in older Italian adults: a population-based study. Sleep Med 11:372–377, doi:10.1016/j.sleep.2009.07.018
92. Mesulam M, Shaw P, Mash D, Weintraub S (2004) Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum. Ann Neurol 55:815–828, doi:10.1002/ana.20100
93. Miyata S, Noda A, Iwamoto K, Kawano N, Okuda M, Ozaki N (2013) Poor sleep quality impairs cognitive performance in older adults. J Sleep Res 22:535–541, doi:10.1111/jsr.12054
94. Monaco F, Fumero S, Mondino A, Mutani R (1979) Plasma and cerebrospinal fluid tryptophan in multiple sclerosis and degenerative diseases. J Neurol Neurosurg Psychiatry 42:640–641
95. Monti JM (2011) Serotonin control of sleep-wake behavior. Sleep Med Rev 15:269–281, doi:10.1016/j.smrv.2010.11.003
96. Mossello E, Boncinelli M, Caleri V, Cavallini MC, Palermo E, Di Bari M, Tilli S, Sarcone E, Simoni D, Biagini CA, Masotti G, Marchionni N (2008) Is antidepressant treatment associated with reduced cognitive decline in Alzheimer’s disease? Dement Geriatr Cogn Disord 25:372–379, doi:10.1159/000121334
97. Mouton PR, Pakkenberg B, Gundersen HJG, Price DL (1994) Absolute number and size of pigmented locus coeruleus neurons in young and aged individuals. J Chem Neuroanat 7:185–190, doi:10.1016/0891-0618(94)90028-0
98. Naidoo N, Zhu J, Zhu Y, Fenik P, Lian J, Galante R, Veasey S (2011) Endoplasmic reticulum stress in wake-active neurons progresses with aging. Aging Cell 10:640–649, doi:10.1111/j.1474-9726.2011.00699.x
99. Nakamura S, Takemura M, Ohnishi K, Suenaga T, Nishimura M, Akiguchi I, Kimura J, Kimura T (1993) Loss of large neurons and occurrence of neurofibrillary tangles in the tuberomammillary nucleus of patients with Alzheimer’s disease. Neurosci Lett 151:196–199
100. Nordberg A, Alafuzoff I, Winblad B (1992) Nicotinic and muscarinic subtypes in the human brain: changes with aging and dementia. J Neurosci Res 31:103–111, doi:10.1002/jnr.490310115
101. Obukuro K, Nobunaga M, Takigawa M, Morioka H, Hisatsune A, Isohama Y, Shimokawa H, Tsutsui M, Katsuki H (2013) Nitric oxide mediates selective degeneration of hypothalamic orexin neurons through dysfunction of protein disulfide isomerase. J Neurosci 33:12557–12568, doi:10.1523/JNEUROSCI.0595-13.2013
102. Ohayon MM, Carskadon MA, Guilleminault C, Vitiello MV (2004) Meta-analysis of quantitative sleep parameters from childhood to old age in healthy individuals: developing normative sleep values across the human lifespan. Sleep 27:1255–1273
103. Ohm TG, Busch C, Bohl J (1997) Unbiased estimation of neuronal numbers in the human nucleus coeruleus during aging. Neurobiol Aging 18:393–399, doi:10.1016/S0197-4580(97)00034-1
104. Overk CR, Kelley CM, Mufson EJ (2009) Brainstem Alzheimer’s-like pathology in the triple transgenic mouse model of Alzheimer's disease. Neurobiol Dis 35:415–425, doi:10.1016/j.nbd.2009.06.004
105. Parkinson J (2002) An essay on the shaking palsy. J Neuropsychiatr 14:223–236, doi:10.1176/appi.neuropsych.14.2.223
106. Parvizi J, Van Hoesen GW, Damasio A (2000) Selective pathological changes of the periaqueductal gray matter in Alzheimer’s disease. Ann Neurol 48:344–353
107. Pat-Horenczyk R, Klauber MR, Shochat T, Ancoli-Israel S (1998) Hourly profiles of sleep and wakefulness in severely versus mild-moderately demented nursing home patients. Aging (Milano) 10:308–315
108. Peter-Derex L, Yammine P, Bastuji H, Croisile B (2014) Sleep and Alzheimer’s disease. Sleep Med Rev 1–10. doi:10.1016/j.smrv.2014.03.007
109. Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, Sutcliffe JG, Kilduff TS (1998) Neurons containing hypocretin (Orexin) project to multiple neuronal systems. J Neurosci 18:9996–10015
110. Platt B, Riedel G (2011) The cholinergic system, EEG and sleep. Behav Brain Res 221:499–504, doi:10.1016/j.bbr.2011.01.017
111. Politis M, Wu K, Loane C, Quinn NP, Brooks DJ, Oertel WH, Björklund A, Lindvall O, Piccini P (2012) Serotonin neuron loss and nonmotor symptoms continue in Parkinson’s patients treated with dopamine grafts. Sci Transl Med 4:128ra41, doi:10.1126/scitranslmed.3003391
112. Prell GD, Khandelwal JK, Burns RS, LeWitt PA, Green JP (1988) Elevated levels of histamine metabolites in cerebrospinal fluid of aging, healthy humans. Compr Gerontol A 2:114–119
113. Ranjan A, Biswas S, Mallick BN (2010) Cytomorphometric changes in the dorsal raphe neurons after rapid eye movement sleep deprivation are mediated by noradrenalin in rats. Behav Brain Funct 6:62, doi:10.1186/1744-9081-6-62
114. Reid KJ, Martinovich Z, Finkel S, Statsinger J, Golden R, Harter K, Zee PC (2006) Sleep: a marker of physical and mental health in the elderly. Am J Geriatr Psychiatry 14:860–866, doi:10.1097/01.JGP.0000206164.56404.ba
115. Rodríguez JJ, Noristani HN, Verkhratsky A (2012) The serotonergic system in ageing and Alzheimer’s disease. Prog Neurobiol 99:15–41, doi:10.1016/j.pneurobio.2012.06.010
116. Roenneberg T, Kuehnle T, Pramstaller PP, Ricken J, Havel M, Guth A, Merrow M (2004) A marker for the end of adolescence. Curr Biol 14:R1038–R1039, doi:10.1016/j.cub.2004.11.039
117. Rogers JD, Brogan D, Mirra SS (1985) The nucleus basalis of Meynert in neurological disease: a quantitative morphological study. Ann Neurol 17:163–170, doi:10.1002/ana.410170210
118. Roussel BD, Kruppa AJ, Miranda E, Crowther DC, Lomas DA, Marciniak SJ (2013) Endoplasmic reticulum dysfunction in neurological disease. Lancet Neurol 12:105–118, doi:10.1016/S1474-4422(12)70238-7
119. Rowland LP (2010) Ameliorating amyotrophic lateral sclerosis. N Engl J Med 362:953–954, doi:10.1056/NEJMcibr0912229
120. Samuels ER, Szabadi E (2008) Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part I: principles of functional organisation. Curr Neuropharmacol 6:235–253, doi:10.2174/157015908785777229
121. Sanchez-Padilla J, Guzman JN, Ilijic E, Kondapalli J, Galtieri DJ, Yang B, Schieber S, Oertel W, Wokosin D, Schumacker PT, Surmeier DJ (2014) Mitochondrial oxidant stress in locus coeruleus is regulated by activity and nitric oxide synthase. Nat Neurosci 17:832–840, doi:10.1038/nn.3717
122. Sandyk R (2006) Serotonergic mechanisms in amyotrophic lateral sclerosis. Int J Neurosci 116:775–826, doi:10.1080/00207450600754087
123. Sawiak SJ, Picq J-L, Dhenain M (2014) Voxel-based morphometry analyses of in vivo MRI in the aging mouse lemur primate. Front Aging Neurosci 6:82, doi:10.3389/fnagi.2014.00082
124. Schenck CH, Boeve BF, Mahowald MW (2013) Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series. Sleep Med 14:744–748, doi:10.1016/j.sleep.2012.10.009
125. Schliebs R, Arendt T (2011) The cholinergic system in aging and neuronal degeneration. Behav Brain Res 221:555–563, doi:10.1016/j.bbr.2010.11.058
126. Schmidt C, Peigneux P, Cajochen C (2012) Age-related changes in sleep and circadian rhythms: impact on cognitive performance and underlying neuroanatomical networks. Front Neurol 3:118, doi:10.3389/fneur.2012.00118
127. Seidel K, Mahlke J, Siswanto S, Krüger R, Heinsen H, Auburger G, Bouzrou M, Grinberg LT, Wicht H, Korf HW, den Dunnen W, Rüb U. (2014) The brainstem pathologies of Parkinson’s disease and dementia with Lewy bodies. Brain Pathol. doi:10.1111/bpa.12168
128. Shaffery JP, Allard JS, Manaye KF, Roffwarg HP (2012) Selective rapid eye movement sleep deprivation affects cell size and number in kitten locus coeruleus. Front Neurol 3:69, doi:10.3389/fneur.2012.00069
129. Shan L, Bossers K, Unmehopa U, Bao AM, Swaab DF (2012a) Alterations in the histaminergic system in Alzheimer’s disease: a postmortem study. Neurobiol Aging 33:2585–2598, doi:10.1016/j.neurobiolaging.2011.12.026
130. Shan L, Liu C-Q, Balesar R, Hofman MA, Bao AM, Swaab DF (2012b) Neuronal histamine production remains unaltered in Parkinson’s disease despite the accumulation of Lewy bodies and Lewy neurites in the tuberomamillary nucleus. Neurobiol Aging 33:1343–1344, doi:10.1016/j.neurobiolaging.2011.01.004
131. Shan L, Swaab DF, Bao A-M (2013) Neuronal histaminergic system in aging and age-related neurodegenerative disorders. Exp Gerontol 48:603–607, doi:10.1016/j.exger.2012.08.002
132. Shibata E, Sasaki M, Tohyama K, Kanbara Y, Otsuka K, Ehara S, Sakai A (2006) Age-related changes in locus ceruleus on neuromelanin magnetic resonance imaging at 3 Tesla. Magn Reson Med Sci 5:197–200
133. Shirokawa T, Ishida Y, Isobe K (2003) Age-related changes in the release and uptake activity of presynaptic axon terminals of rat locus coeruleus neurons. Neurosci Lett 344:212–214, doi:10.1016/S0304-3940(03)00463-4
134. Shores MM, White SS, Veith RC, Szot P (1999) Tyrosine hydroxylase mRNA is increased in old age and norepinephrine uptake transporter mRNA is decreased in middle age in locus coeruleus of Brown-Norway rats. Brain Res 826:143–147
135. Sims RE, Wu HHT, Dale N (2013) Sleep-wake sensitive mechanisms of adenosine release in the basal forebrain of rodents: an in vitro study. PLoS One 8:e53814, doi:10.1371/journal.pone.0053814
136. Sotiriou E, Vassilatis DK, Vila M, Stefanis L (2010) Selective noradrenergic vulnerability in α-synuclein transgenic mice. Neurobiol Aging 31:2103–2114, doi:10.1016/j.neurobiolaging.2008.11.010
137. Stanley EM, Fadel J (2012) Aging-related deficits in orexin/hypocretin modulation of the septohippocampal cholinergic system. Synapse 66:445–452, doi:10.1002/syn.21533
138. Steriade M (2004) Acetylcholine systems and rhythmic activities during the waking–sleep cycle. Prog Brain Res 145:179–196, doi:10.1016/S0079-6123(03)45013-9
139. Takahashi K, Kayama Y, Lin JS, Sakai K (2010) Locus coeruleus neuronal activity during the sleep-waking cycle in mice. Neuroscience 169:1115–1126, doi:10.1016/j.neuroscience.2010.06.009
140. Thannickal TC, Moore RY, Nienhuis R, Ramanathan L, Gulyani S, Aldrich M, Cornford M, Siegel JM (2000) Reduced number of hypocretin neurons in human narcolepsy. Neuron 27:469–474, doi:10.1016/S0896-6273(00)00058-1
141. Thannickal TC, Lai Y-Y, Siegel JM (2007) Hypocretin (orexin) cell loss in Parkinson’s disease. Brain 130:1586–1595, doi:10.1093/brain/awm097
142. Tohgi H, Abe T, Takahashi S, Kimura M, Takahashi J, Kikuchi T (1992) Concentrations of serotonin and its related substances in the cerebrospinal fluid in patients with Alzheimer type dementia. Neurosci Lett 141:9–12, doi:10.1016/0304-3940(92)90322-X
143. Tohgi H, Abe T, Takahashi S, Takahashi J, Hamato H (1993) Concentrations of serotonin and its related substances in the cerebrospinal fluid of Parkinsonian patients and their relations to the severity of symptoms. Neurosci Lett 150:71–74, doi:10.1016/0304-3940(93)90111-W
144. Tsunematsu T, Kilduff TS, Boyden ES, Takahashi S, Tominaga M, Yamanaka A (2011) Acute optogenetic silencing of orexin/hypocretin neurons induces slow-wave sleep in mice. J Neurosci 31:10529–10539, doi:10.1523/JNEUROSCI.0784-11.2011
145. Turner MR, Rabiner EA, Hammers A, Al-Chalabi A, Grasby PM, Shaw CE, Brooks DJ, Leigh PN (2005) [11C]-WAY100635 PET demonstrates marked 5-HT1A receptor changes in sporadic ALS. Brain 128:896–905, doi:10.1093/brain/awh428
146. Uchida S, Hotta H, Misawa H, Kawashima K (2013) The missing link between long-term stimulation of nicotinic receptors and the increases of acetylcholine release and vasodilation in the cerebral cortex of aged rats. J Physiol Sci 63:95–101, doi:10.1007/s12576-012-0239-2
147. Uehara T, Nakamura T, Yao D, Shi ZQ, Gu Z, Ma Y, Masliah E, Nomura Y, Lipton SA (2006) S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature 441:513–517, doi:10.1038/nature04782
148. Valko PO, Gavrilov YV, Yamamoto M, Reddy H, Haybaeck J, Mignot E, Baumann CR, Scammell TE (2013) Increase of histaminergic tuberomammillary neurons in narcolepsy. Ann Neurol 74:794–804, doi:10.1002/ana.24019
149. Van Luijtelaar MGPA, Steinbusch HWM, Tonnaer JADM (1988) Aberrant morphology of serotonergic fibers in the forebrain of the aged rat. Neurosci Lett 95:93–96, doi:10.1016/0304-3940(88)90638-6
150. Van Luijtelaar MGPA, Tonnaer JADM, Steinbusch HWM (1992) Aging of the serotonergic system in the rat forebrain: an immunocytochemical and neurochemical study. Neurobiol Aging 13:201–215, doi:10.1016/0197-4580(92)90032-S
151. Vitiello MV, Bliwise DL, Prinz PN (1992) Sleep in Alzheimer’s disease and the sundown syndrome. Neurology 42:83–93, discussion 93–4
152. Von Coelln R, Thomas B, Savitt JM, Lim KL, Sasaki M, Hess EJ, Dawson VL, Dawson TM (2004) Loss of locus coeruleus neurons and reduced startle in parkin null mice. Proc Natl Acad Sci U S A 101:10744–10749, doi:10.1073/pnas.0401297101
153. Wade AG, Farmer M, Harari G, Fund N, Laudon M, Nir T, Frydman-Marom A, Zisapel N (2014) Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer’s disease: a 6-month, randomized, placebo-controlled, multicenter trial. Clin Interv Aging 9:947–961, doi:10.2147/CIA.S65625
154. Weishaupt JH, Bartels C, Pölking E, Dietrich J, Rohde G, Poeggeler B, Mertens N, Sperling S, Bohn M, Hüther G, Schneider A, Bach A, Sirén AL, Hardeland R, Bähr M, Nave KA, Ehrenreich H (2006) Reduced oxidative damage in ALS by high-dose enteral melatonin treatment. J Pineal Res 41:313–323, doi:10.1111/j.1600-079X.2006.00377.x
155. Wennberg AM, Canham SL, Smith MT, Spira AP (2013) Optimizing sleep in older adults: treating insomnia. Maturitas 76:247–252, doi:10.1016/j.maturitas.2013.05.007
156. Wennström M, Londos E, Minthon L, Nielsen HM (2012) Altered CSF orexin and α-synuclein levels in dementia patients. J Alzheimers Dis 29:125–132, doi:10.3233/JAD-2012-111655
157. Wilson RS, Nag S, Boyle PA, Hizel LP, Yu L, Buchman AS, Schneider JA, Bennett DA (2013) Neural reserve, neuronal density in the locus ceruleus, and cognitive decline. Neurology 80:1202–1208, doi:10.1212/WNL.0b013e3182897103
158. Wolf D, Grothe M, Fischer FU, Heinsen H, Kilimann I, Teipel S, Fellgiebel A (2014) Association of basal forebrain volumes and cognition in normal aging. Neuropsychologia 53:54–63, doi:10.1016/j.neuropsychologia.2013.11.002
159. Xie L, Kang H, Xu Q, Chen MJ, Liao Y, Thiyagarajan M, O'Donnell J, Christensen DJ, Nicholson C, Iliff JJ, Takano T, Deane R, Nedergaard M (2013) Sleep drives metabolite clearance from the adult brain. Science 342:373–377, doi:10.1126/science.1241224
160. Xu A, Sakurai E, Kuramasu A, Zhang J, Li J, Okamura N, Zhang D, Yoshikawa T, Watanabe T, Yanai K (2010) Roles of hypothalamic subgroup histamine and orexin neurons on behavioral responses to sleep deprivation induced by the treadmill method in adolescent rats. J Pharmacol Sci 114:444–453
161. Yanai K, Watanabe T, Meguro K, Yokoyama H, Sato I, Sasano H, Itoh M, Iwata R, Takahashi T, Ido T (1992) Age-dependent decrease in histamine H1 receptor in human brains revealed by PET. Neuroreport 3:433–436
162. Yang Y, Schmitt HP (2001) Frontotemporal dementia: evidence for impairment of ascending serotoninergic but not noradrenergic innervation. Immunocytochemical and quantitative study using a graph method. Acta Neuropathol 101:256–270
163. Zarow C, Lyness SA, Mortimer JA, Chui HC (2003) Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. Arch Neurol 60:337–341
164. Zemek F, Drtinova L, Nepovimova E, Sepsova V, Korabecny J, Klimes J, Kuca K (2014) Outcomes of Alzheimer’s disease therapy with acetylcholinesterase inhibitors and memantine. Expert Opin Drug Saf 13:759–774, doi:10.1517/14740338.2014.914168
165. Zhan G, Serrano F, Fenik P, Hsu R, Kong L, Pratico D, Klann E, Veasey SC (2005) NADPH oxidase mediates hypersomnolence and brain oxidative injury in a murine model of sleep apnea. Am J Respir Crit Care Med 172:921–929, doi:10.1164/rccm.200504-581OC
166. Zhang Y-Q, Mei J, Lü S-G, Zhao Z-Q (2002) Age-related alterations in responses of Nucleus basalis magnocellularis neurons to peripheral nociceptive stimuli. Brain Res 948:47–55, doi:10.1016/S0006-8993(02)02947-5
167. Zhang J-H, Sampogna S, Morales FR, Chase MH (2005) Age-related changes of hypocretin in basal forebrain of guinea pig. Peptides 26:2590–2596, doi:10.1016/j.peptides.2005.05.003
168. Zhang J, Zhu Y, Zhan G, Fenik P, Panossian L, Wang MM, Reid S, Lai D, Davis JG, Baur JA, Veasey S (2014) Extended wakefulness: compromised metabolics in and degeneration of locus ceruleus neurons. J Neurosci 34:4418–4431, doi:10.1523/JNEUROSCI.5025-12.2014
169. Zhu M-Y, Wang W-P, Iyo AH, Ordway GA, Kim KS (2005) Age-associated changes in mRNA levels of Phox2, norepinephrine transporter and dopamine beta-hydroxylase in the locus coeruleus and adrenal glands of rats. J Neurochem 94:828–838, doi:10.1111/j.1471-4159.2005.03245.x
170. Zhu Y, Fenik P, Zhan G, Mazza E, Kelz M, Aston-Jones G, Veasey SC (2007) Selective loss of catecholaminergic wake active neurons in a murine sleep apnea model. J Neurosci 27:10060–10071, doi:10.1523/JNEUROSCI.0857-07.2007